Your browser doesn't support javascript.
loading
Treatment of Hepatocellular Carcinoma by Multimodal In Situ Vaccination Using Cryoablation and a Plant Virus Immunostimulant.
Ghani, Mansur A; Bangar, Amandip; Yang, Yunpeng; Jung, Eunkyeong; Sauceda, Consuelo; Mandt, Tyler; Shukla, Sourabh; Webster, Nicholas J G; Steinmetz, Nicole F; Newton, Isabel G.
  • Ghani MA; Department of Radiology, University of California San Diego, La Jolla, California.
  • Bangar A; Department of Radiology, University of California San Diego, La Jolla, California.
  • Yang Y; Department of Radiology, University of California San Diego, La Jolla, California.
  • Jung E; Department of NanoEngineering, University of California San Diego, La Jolla, California.
  • Sauceda C; Department of Pharmacology, University of California San Diego, La Jolla, California; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California.
  • Mandt T; Department of Radiology, University of California San Diego, La Jolla, California.
  • Shukla S; Department of NanoEngineering, University of California San Diego, La Jolla, California.
  • Webster NJG; Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California; Moores Cancer Center, University of California San Diego, La Jolla, California; VA San Diego Healthcare System, San Diego, California.
  • Steinmetz NF; Department of Radiology, University of California San Diego, La Jolla, California; Department of NanoEngineering, University of California San Diego, La Jolla, California; Moores Cancer Center, University of California San Diego, La Jolla, California; Department of Bioengineering, University of Cali
  • Newton IG; Department of Radiology, University of California San Diego, La Jolla, California; VA San Diego Healthcare System, San Diego, California. Electronic address: inewton@health.ucsd.edu.
J Vasc Interv Radiol ; 34(7): 1247-1257.e8, 2023 07.
Article en En | MEDLINE | ID: mdl-36997021
ABSTRACT

PURPOSE:

To test the hypothesis that cryoablation combined with intratumoral immunomodulating nanoparticles from cowpea mosaic virus (CPMV) as an in situ vaccination approach induces systemic antitumoral immunity in a murine model of hepatocellular carcinoma (HCC). MATERIALS AND

METHODS:

Mice with bilateral, subcutaneous RIL-175 cell-derived HCCs were randomized to 4 groups (a) phosphate-buffered saline (control), (b) cryoablation only (Cryo), (c) CPMV-treated only (CPMV), and (d) cryoablation plus CPMV-treated (Cryo + CPMV) (N = 11-14 per group). Intratumoral CPMV was administered every 3 days for 4 doses, with cryoablation performed on the third day. Contralateral tumors were monitored. Tumor growth and systemic chemokine/cytokine levels were measured. A subset of tumors and spleens were harvested for immunohistochemistry (IHC) and flow cytometry. One- or 2-way analysis of variance was performed for statistical comparisons. A P value of <.05 was used as the threshold for statistical significance.

RESULTS:

At 2 weeks after treatment, the Cryo and CPMV groups, alone or combined, outperformed the control group in the treated tumor; however, the Cryo + CPMV group showed the strongest reduction and lowest variance (1.6-fold ± 0.9 vs 6.3-fold ± 0.5, P < .0001). For the untreated tumor, only Cryo + CPMV significantly reduced tumor growth compared with control (9.2-fold ± 0.9 vs 17.8-fold ± 2.1, P = .01). The Cryo + CPMV group exhibited a transient increase in interleukin-10 and persistently decreased CXCL1. Flow cytometry revealed natural killer cell enrichment in the untreated tumor and increased PD-1 expression in the spleen. Tumor-infiltrating lymphocytes increased in Cryo + CPMV-treated tumors by IHC.

CONCLUSIONS:

Cryoablation and intratumoral CPMV, alone or combined, demonstrated potent efficacy against treated HCC tumors; however, only cryoablation combined with CPMV slowed the growth of untreated tumors, consistent with an abscopal effect.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Comovirus / Carcinoma Hepatocelular / Criocirugía / Neoplasias Hepáticas Tipo de estudio: Clinical_trials Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Comovirus / Carcinoma Hepatocelular / Criocirugía / Neoplasias Hepáticas Tipo de estudio: Clinical_trials Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article